Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):517–523. doi: 10.1161/CIRCOUTCOMES.113.000691

Table 1.

Baseline Characteristics of Patients Surviving and Not Surviving to Hospital Discharge

No. (%)(N =1551) Survivors (n=543) Non-Survivors (n= 1008) P value
Demographics
 Age groups <0.001
  Neonates (0–1 month) 481 (31.0) 165 (30.4) 316 (31.3)
  Infants (1–12 months) 358 (23.1) 167 (30.8) 191 (18.9)
  Young Children (1–8 years) 358 (23.1) 120 (22.1) 238 (23.6)
  Older Children (8–18 years) 354 (22.8) 91 (16.8) 263 (26.1)
 Male Sex 900 (58.0) 301(55.4) 599(59.4) 0.13
 Race 0.01
  White 853 (55.0) 318 (58.6) 535 (53.1)
  Black 333 (21.5) 103 (19.0) 230 (22.8)
  Other 199 (12.8) 78 (14.4) 121 (12.0)
  Unknown 166 (10.7) 44 (8.1) 122 (12.1)
Event Characteristics
 Initial Rhythm 0.03
  Asystole 526 (33.9) 166 (30.6) 360 (35.7)
  PEA 835 (53.8) 295 (54.3) 540 (53.6)
  VF 102 (6.6) 42 (7.7) 60 (6.0)
  Pulseless VT 88 (5.7) 40 (7.4) 48 (4.8)
 Night* (11pm to 6:59am) 429 (27.9) 140 (26.0) 289 (28.9) 0.23
 Weekend (11pm Fri to 6:59am Mon) 457 (29.5) 137 (25.2) 320 (31.7) 0.007
 Location <0.001
  ICU 1042 (67.2) 368 (67.8) 674 (66.9)
  Procedure areas 117 (7.5) 61 (11.2) 56 (5.6)
  ED 215 (13.9) 45 (8.3) 170 (16.9)
  Monitored 39 (2.5) 12 (2.2) 27 (2.7)
  Unmonitored 86 (5.5) 36 (6.6) 50 (5.0)
  Other 52 (3.4) 21(3.9) 31 (3.1)
Illness Category <0.001
 Med-Cardiac 221 (14.2) 86 (15.8) 135 (13.4)
 Med-Noncardiac 540 (34.8) 164 (30.2) 376 (37.3)
 Surg-Cardiac 332 (21.4) 156 (28.7) 176 (17.5)
 Surg-Noncardiac 125 (8.1) 54 (9.9) 71 (7.0)
 Other 333 (21.5) 83 (15.3) 250 (24.8)
Pre-Existing Conditions
 Heart failure this admission 108 (7.0) 41 (7.6) 67 (6.6) 0.51
 Heart failure prior to admission 82 (5.3) 27 (5.0) 55 (5.5) 0.69
 Arrhythmia 332 (21.4) 123 (22.7) 209 (20.7) 0.38
 Hypotension 594 (38.3) 175 (32.2) 419 (41.6) <0.001
 Respiratory insufficiency 932 (60.1) 323 (59.5) 609 (60.4) 0.72
 Renal insufficiency 150 (9.7) 28 (5.2) 122 (12.1) <0.001
 Hepatic insufficiency 59 (3.8) 11 (2.0) 48 (4.8) 0.007
 Metabolic or electrolyte abnormality 290 (18.7) 78 (14.4) 212 (21.0) 0.001
 Baseline depression in CNS function 216 (13.9) 65 (12.0) 151 (15.0) 0.10
 Acute CNS non-stroke event 116 (7.5) 23 (4.2) 93 (9.2) <0.001
 Pneumonia 106 (6.8) 41(7.6) 65 (6.4) 0.41
 Sepsis 220 (14.2) 55 (10.1) 165 (16.4) <0.001
 Major trauma 164 (10.6) 24 (4.4) 140 (13.9) <0.001
 Metastatic or hematologic malignancy 73 (4.7) 7 (1.3) 66 (6.5) <0.001
Interventions in Place
 Assisted/mechanical ventilation 1004 (64.7) 329 (60.6) 675 (67.0) 0.01
 Intravenous antiarrhythmics 69 (4.4) 35(6.4) 34 (3.4) 0.005
 Intravenous vasopressors 628 (40.5) 175 (32.2) 453 (44.9) <0.001

Abbreviations: PEA, pulseless electrical activity; VF, ventricular fibrillation; VT, ventricular tachycardia; ICU, intensive care unit; ED, emergency department; CNS, central nervous system; Mon, Monday; Fri, Friday

*

13 patients (5 survivors, 8 non-survivors) with missing data for time of cardiac arrest